USA flag logo/image

An Official Website of the United States Government

13C-Erythromycin Breath Test to Determine Drug Dosages

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
25105
Program Year/Program:
1996 / SBIR
Agency Tracking Number:
25105
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
METABOLIC SOLUTIONS, INC.
METABOLIC SOLUTIONS, INC. 460 AMHERST ST NASHUA, NH 03063
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1996
Title: 13C-Erythromycin Breath Test to Determine Drug Dosages
Agency: HHS
Contract: 1 R43 GM50667-1,
Award Amount: $723,351.00
 

Abstract:

We will develop a nonradioactive, noninvasive breath test to predict blood drug levels. We willdevelop a 13C breath test to measure cytochrome P450IIIA enzyme activity. Many drugs, such ascyclosporine, are metabolized by this p450 family. The catalytic activity of p450IIIA will be estimatedfrom the rate at which a patient exhales 13CO2 after receiving an oral dose of [N,N-dimethyl-13C2]-eryt-hromycin. In previous studies, we showed that an intravenous dose of radioactive 14C-erythromycinwould be N-demethylated by P450IIIA enzymes. The production of breath 14CO2 correlated withP450IIIA levels and catalytic activity. Further research showed that the 14C-erythromycin breath testaccurately predicts cyclosporine blood levels in patients receiving different dosages. The activity ofP450IIIA varies ten fold in humans and may account for heterogeneity of cyclosporine dosingrequirements. Knowledge of P450IIIA activity could predict a cyclosporine blood level for a given drugdosage. The clinician will utilize this information to prevent either potentially subtherapeutic orpotentially toxic dosages of cyclosporine to be administered to patients. The correct dosage ofcyclosporine could be achieved in a shorter hospital stay with this breath test compared to the currentmethod of measuring blood levels.

Principal Investigator:

David Wagner
5086359914

Business Contact:

Small Business Information at Submission:

Metabolic Solutions, Inc.
7 Henry Clay Drive Merrimack, NH 03054

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No